According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,31ย โฌ. In 2022 the company made an earnings per share (EPS) of -1,30ย โฌ a decrease over its 2021 EPS that were of -1,11ย โฌ.